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The Abbott yeast identification system (Abbott Laboratories, Diagnostics Division, Irving, Tex.) is a 24-
h, instrumental method for identifying medically important yeasts, based on matrix analysis of 19
biochemical reactions and the germ tube test. The system was evaluated in two clinical laboratories by using
179 coded isolates, which included a high percentage of the less frequently encountered species. Based upon
results with these coded isolates and from previously obtained laboratory data, the system software was
adjusted and accuracy of the yeast identification system was further evaluated with 378 isolates from clinical
sources. Of the 378 clinical yeast isolates tested, 364 (96%) were correctly identified with the Abbott
system. Isolates were deliberately selected so that germ tube-positive isolates made up less than 10% of the
clinical isolates tested.
The mycology section of most clinical laboratories pro-
duces results with an inherent slowness that can be generally
attributed to the growth rates of the various fungi being
studied. However, with the increase in awareness of the
morbidity and mortality (1, 2, 5, 9, 10, 12, 17) associated with
opportunistic infections caused by yeasts, it has become
important to investigate rapid and automated methods for
the rapid and specific diagnosis of these infections. The toxic
medications that are necessary for treating invasive infec-
tions caused by yeasts are used only when necessary by
prudent physicians. For this reason, it is important to rapidly
detect and identify pathogenic yeasts so that the decision to
use an antimycotic drug can be made while the pathological
process caused by an invasive infection is still reversible.
With this in mind, it has been of interest to investigate the
feasibility of using the Abbott MS-2 instrument (MS-2) for
performing biochemical tests for identifying clinical yeast
isolates. The MS-2 has previously been evaluated for identi-
fying enteric bacteria and was shown to yield reliable results
(15). Automated approaches to performing biochemical tests
for identifying yeasts that have previously been described
have used the Autobac 1 (18, 21) or the AutoMicrobic
system Yeast Biochemical Card (11, 19). Biochemical tests
with these two instruments could be completed in 12 h with
the Autobac 1 and in 24 h with the AutoMicrobic system.
Conventional methods for identifying clinical yeast iso-
lates can require as long as 14 to 28 days for completion of
biochemical tests (14, 20, 22). The newer miniaturized
systems such as the API 20C, the BBL Minitek Yeast
system, and Uni-Yeast-Tek provide biochemical testing in 3
to 7 days with an acceptable level of reliability (3, 4, 7, 13,
16).
In this report, we describe the development and clinical
testing of the Abbott yeast identification system (Abbott
IDS). Preliminary developmental studies with this system
have been reported previously (6; B. H. Cooper, S. Prowant,
D. Brunson, and R. Vannest, Abstr. Annu. Meet. Am. Soc.
Microbiol. 1982, C274, p. 317).
MATERIALS AND METHODS
Protocol and organisms. These studies were carried out in
two phases. Phase 1 consisted of testing 179 previously
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identified and coded yeast isolates obtained from culture
collections at Baylor University Medical Center and the
North Carolina Memorial Hospital. These coded cultures
were submitted as unknowns to the participants for identifi-
cation. Phase 2 consisted of testing fresh clinical isolates
obtained in the participating centers along with some isolates
submitted from other laboratories. These clinical isolates
were first screened by the germ tube test (20). The number of
germ tube-positive (i.e., Candida albicans) isolates tested
was restricted to less than 10% of the clinical isolates tested.
A total of 378 yeast isolates were evaluated in this phase.
The Abbott IDS results were compared with findings ob-
tained by each clinical laboratory by using their current
identification method. When a discrepancy was observed
between an Abbott IDS identification and the routine lab test
result, morphology data and conventional reference testing
with the Wickerham broth carbohydrate assimilation media,
nitrate assimilation, a test for phenol oxidase activity, and
Christensen urea agar were used to establish identification.
When necessary, fermentation tests were also used to verify
an identification.
Abbott IDS. The MS-2 system modules have been de-
scribed previously (15). The Abbott yeast identification
cartridge is a single-use disposable plastic unit consisting of
20 chambers containing lyophilized biochemical media. The
active substrates in the cartridge are as follows: urea, p-
hydroxybenzoic acid and protocatechuic acid, negative con-
trol, glucose, galactose, sucrose, maltose, cellobiose, treha-
lose, lactose, melibiose, raffinose, melizitose, xylose,
arabinose, rhamnose, erythritol, dulcitol, inositol, and ni-
trate. With the exception of the test for assimilation of the
mixture of p-hydroxybenzoic acid and protocatechuic acid,
the biochemical tests utilized are those routinely employed
in conventional identification systems (14, 20, 22). The
utility of a test for p-hydroxybenzoic acid utilization, as an
aid to identification of Candida parapsilosis and certain
other yeasts, has already been described (8).
Well-isolated yeast colonies from Sabouraud agar plates,
incubated for 24 to 48 h at 30°C, were used to prepare the
inocula. Colonies of a test organism were selected and, by
using a sterile inoculating loop or cotton-tipped applicator,
were suspended in 0.05% Noble agar to prepare a slightly
turbid suspension which visually matched the turbidity of a
0.5 McFarland standard. The suspension was mixed on a
vortex mixer, and 0.2-ml portions were delivered into each
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chamber of the Abbott IDS cartridge. The cartridge was then
sealed with a polyester film to eliminate any adverse effects
that volatile metabolic end products might have on adjacent
reactions. An initial reading of the optical density of each
reaction chamber in the cartridge was taken with the MS-2,
and these data were automatically stored in the computer
memory. Cartridges were then incubated off-line at 30°C for
22 to 25 h, after which they were reinserted into the MS-2 for
a final reading. After the final reading, results of several
morphological tests and additional test results were entered
via computer keyboard to provide a comprehensive record
of these studies. These tests included morphological obser-
vations for detecting hyphae, chlamydospores, arthroconi-
dia, germ tube formation, and capsules and for measuring
growth at 37°C and phenol oxidase activity. Such determina-
tions were made by conventional methodology (14, 20) and
were set up at the time the isolates were subcultured, before
inoculation of the cartridge. These ancillary tests were read
before the final reading of the yeast cartridges. It was
subsequently determined that only the germ tube test results
were needed as ancillary input. The MS-2 data printout
included a record of the positive and negative biochemical
reactions, the identity of the yeasts (with up to five species
listed in descending order of likelihood), and a percent
likelihood value for each species listed.
Laboratory identification procedures. In these studies,
each collaborating laboratory used its current routine meth-
odology for identifying clinical yeast isolates. The Abbott
IDS results were compared with those identifications. Rou-
tine methods were predominantly API 20C (Analytab Prod-
ucts, Plainview, N.Y.) or Uni-Yeast-Tek (Flow Labora-
tories, Inc., MacLean, Va.), used in accordance with the
instructions of the manufacturer. As noted previously, any
discrepant results were resolved by testing with classical
reference methodology (14, 20, 22).
Data evaluation. Accuracy of the Abbott IDS results with
coded isolates was analyzed initially in two ways: (i) by
considering both cartridge biochemical results and all mor-
phological tests (germ tube formation, capsules, chlamydo-
spores, hyphae, and arthroconidia); and (ii) by considering
only the biochemical and germ tube test data. Results
obtained with coded isolates were also used to make adjust-
ments to the MS-2 analytical program before final analysis of
results with clinical isolates. Data from clinical isolates were
analyzed with only the biochemical and germ tube test
results. Abbott IDS results were considered correct if they
agreed with either the initial routine laboratory identifica-
tion, or, in the case of a discrepancy, the result of subse-
quent extensive reference testing.
RESULTS
Abbott IDS accuracy with the collection of coded isolates
is shown in Table 1. The values shown reflect results with
either only the MS-2 cartridge data and germ tube results or
all morphology data included in the computer-calculated
results. When used, morphological data were weighed equal-
ly with any single biochemical test result. The Abbott IDS
results shown in all tables reflect results with final software
modifications in place. The coded isolate collection was
limited to contain only 5% (8 of 179) C. albicans, but did
include 10% (18 of 179) Geotrichum and Trichosporon spp.
The remaining 153 isolates were distributed among the
remaining species as shown in Table 2. Considering only
biochemical and germ tube test results, the accuracy of the
Abbott IDS in the two laboratories was, respectively, 93 and
89%. In this initial phase, species that were most difficult to
TABLE 1. Accuracy of identification of coded isolates by Abbott
IDS with germ tube test results and with corn meal morphology
No. correct No.Laboratory Method No. incorrect
1 IDS and germ tube 166 (93) 13 (7)
test
IDS and corn meal 169 (94) 10 (5)
morphology
2 IDS and germ tube 159 (89) 20 (11)
test
IDS and corn meal 165 (92) 14 (8)
morphology
identify in both laboratories included Trichosporon beigelii,
Geotrichum spp., Candida famata, and Candida humicola.
Combined results from 378 clinical strains isolated in the
two participating laboratories and from other sources in
phase 2 of the study are shown in Table 3. Correct identifica-
tions were obtained with 364 (96%) of these isolates with the
TABLE 2. Accuracy of Abbott IDS with coded isolates
No. of correctly
No. of identified isolates




albicans 9 8 9
famata 3 1 1
glabrata 10 10 10
guilliermondii 9 9 7
humicola 3 0 0
krusei 10 9 7
lambica 1 1 1
lipolytica 4 3 4
lusitaniae 5 5 4
parapsilosis 12 11 11
pseudotropicalis 4 4 4
rugosa 3 3 3
stellatoidea 5 5 5
tropicalis 15 15 15
utilis 3 3 2
Cryptococcus
albidus 8 8 8
laurentii 7 7 7
luteolus 4 4 4
neoformans 12 12 12
skinneri 1 1 1
terreus 5 5 5
uniguttulatus 4 4 4
Geotrichum capitatum 6 5 2
Geotrichum spp. 8 6 7
Hansenula anomala 1 1 1
Rhodotorula
glutinis 1 1 1
minuta 1 1 0
pilimanae 2 2 2
rubra 12 12 12
Saccharomyces cerevisiae 7 7 7
Trichosporon beigelii 4 3 3
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Abbott IDS. Of the 14 discrepancies, 8 (57%) were accompa-
nied by a warning message indicating a low likelihood of
correct identification (less than 80%). Conversely, of those
isolates correctly identified by the Abbott IDS, only eight
(2%) were accompanied by a low-likelihood statement indi-
cating the advisability of additional testing. Of the 16 total
low-likelihood situations encountered, 11(69%) would have
been effectively resolved by morphological observation
alone.
DISCUSSION
The data presented here illustrate the capability of the
Abbott IDS for performing biochemical tests used in identi-
fying medically important yeasts. Reliable results were ob-
tained, and the tests were completed in just 20 to 24 h. A high
level of agreement with conventional test results (96%) was
achieved by using only the germ tube test results and
biochemical tests with clinical isolates in phase 2 of the
study. The more time-consuming studies of microscopic
morphology on corn meal agar were not necessary with most
isolates. Even clinical isolates belonging to the genera Tri-
chosporon and Geotrichum could frequently be identified
without morphological observations. However, it should be
pointed out that isolates belonging to those two genera
present a significant challenge to any identification system.
It is desirable to have available morphological test results
along with biochemical test results for identifying such
clinical yeast isolates, when using the Abbott IDS system on
a routine basis.
The overall agreement with conventional test results was-
somewhat lower (91%) in phase 1 of the study, in which
blind-coded isolates were identified, than in phase 2, which
involved routine clinical isolates. Two important factors
contributed to this difference. First, the spectrum of isolates
tested in phase 1 included a number of rare and unusual
isolates. This wide range of organisms was deliberately
selected to challenge the system at a maximum level. Some
isolates were included that have not been reported to cause
human disease and are rarely encountered in clinical labora-
tories. Secondly, the results obtained in phase 1 were used to
further refine the data matrix so that more accurate results
could be obtained. This factor contributed significantly to
the improved correlation observed with conventional test
results and clinical isolates in phase 2.
The availability of a means for rapid, automated identifica-
tion of yeasts significantly expands the capabilities of the
Abbott IDS system. The ability to complete biochemical
tests within 20 to 24 h after the test initiation offers a
significant saving of time compared with both conventional
tube tests and currently available manual systems. More
rapid identification of pathogenic species of yeasts is a
significant step toward the goal of diagnosing invasive yeast
infections in sufficient time to enable effective treatment to
be administered before the pathological process becomes
irreversible.
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